A study on melatonin and Vitamin C and zinc efficacy in patients with COVID19

Phase 2

• Conditions: U07.01; Covid-19.; Covid-19 infection

• Registration Number: IRCT20151228025732N52
• Lead Sponsor: Semnan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 15 June 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Patients with Covid 19
Conscious consent of the patient

Exclusion Criteria

Malignant diseases
Severe renal, hepatic failure
History of drug allergy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of breaths per minute. Timepoint: Before the intervention, from the start of treatment to the patient's recovery. Method of measurement: Vital signs monitoring devices.;The rate of decline of lung infection. Timepoint: Before the intervention, from the start of treatment to the patient's recovery. Method of measurement: Clinical examination, if necessary, radiography or CT scan.;The course of the disease. Timepoint: Before the intervention, from the start of treatment to the patient's recovery. Method of measurement: Clinical examination, if necessary, radiography or CT scan.;Heart rate. Timepoint: Before the intervention, from the start of treatment to the patient's recovery. Method of measurement: Vital signs monitoring devices.